Levels and prognostic significance of serum procalcitonin and D-dimer in children with systemic inflammatory response syndrome

doi:10.7499/j.issn.1008-8830.2014.04.015

PDF(1442 KB)

Chinese Journal of Contemporary Pediatrics ›› 2014, Vol. 16 ›› Issue (4) : 384-388. DOI: 10.7499/j.issn.1008-8830.2014.04.015

CLINICAL RESEARCH

Levels and prognostic significance of serum procalcitonin and D-dimer in children with systemic inflammatory response syndrome

QI Ying-Zheng, Duolikun MUZHAPER

Author information +

History +

Abstract

Objective To evaluate the prognostic significance of serum levels of procalcitonin (PCT) and D-dimer in children with systemic inflammatory response syndrome (SIRS). Methods A prospective case control study was conducted on 67 pediatric patients with SIRS who were treated in the pediatric intensive care unit (PICU). Based on the presence or absence of infectious lesions, patients were categorized as sepsis and non-sepsis. Within 24 hours after admission, white blood cell (WBC) count and serum levels of PCT, C-reactive protein (CRP) and D-dimer were determined, and the pediatric critical illness score (PCIS) was calculated. The correlation of PCIS with each of the other measurements was analyzed. On day 28 of follow-up, receiver operator characteristic (ROC) curve was plotted, and the area under ROC (AUC) was calculated. 28-day survival was estimated. Multivariate logistic regression analysis was performed to identify independent risk factors for in-hospital mortality. Results Serum levels of PCT and D-dimer were significantly higher (P<0.05) but PCIS was significantly lower (P<0.05) in patients with sepsis than in those without sepsis. Both PCT and D-dimer were negatively correlated with PCIS (P<0.01). Serum levels of PCT and D-dimer 24 hours after admission were higher (P<0.05) and PCIS was lower (P<0.05) in non-survivors than in survivors on day 28. AUC was 0.875, 0.872 and 0.863 respectively for PCT, D-dimer and PCIS in the prediction of 28-day survival (P<0.01). Logistic regression analysis revealed that PCT and D-dimer were independent prognostic factors (odd ratio: 1.684 and 1.003; P<0.01). Conclusions Serum levels of PCT may be helpful in differentiating sepsis and non-sepsis at early stage of SIRS in children. PCT and D-dimer are independent risk factors for in-hospital mortality in children with SIRS, and thus have a prognostic significance in clinical settings.

Key words

Procalcitonin / D-dimer / Systemic Inflammatory response syndrome / Prognosis / Child

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

QI Ying-Zheng, Duolikun MUZHAPER. Levels and prognostic significance of serum procalcitonin and D-dimer in children with systemic inflammatory response syndrome[J]. Chinese Journal of Contemporary Pediatrics. 2014, 16(4): 384-388 https://doi.org/10.7499/j.issn.1008-8830.2014.04.015

References

[1] Bone RC, Balk RA, Cerra FB, et al. Definition for sepsis and organ failure and guideline for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee[J].Chest, 1992, 101(6): 1644-1655.
[2] Standage SW, Wong HR. Biomarkers for pediatric sepsis and septic shock[J]. Expert Rev Anti Infer Ther, 2011, 9(1): 71-79.
[3] Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics[J]. Pediatric Crit Care Med, 2005, 6 (1): 2-8.
[4] 中华医学会儿科学会急救组. 小儿危重病例评分法(草案)[J].中华儿科杂志, 1995, 33(6): 370-373.
[5] 汪芸, 李尔珍．降钙素原在临床的应用研究进展[J]. 实用儿科临床杂志, 2007, 18(3): 1427.
[6] Sponholz C, Sakr Y, Reinhart K, et al. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature[J]. Crit Care, 2006, 10(5): R145.
[7] Indino P, Lemarch P, Bady P, et al. Prospective study on procalcitonin and other systemic infection markers in patients with Leukocytosis[J]. Int J Infect Dis, 2008, 12(3): 319-324.
[8] Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection[J]. Lancet, 1993, 341(27): 515-518.
[9] Castelli GP, Pognani C, Cita M, et al. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis[J]. Minerva Anestesiol, 2006, 72(1-2): 69-80.
[10] Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis[J]. Lancet Infect Dis, 2007, 7(3): 210-217.
[11] Liu YJ, Du P, Rao J. Procalcitonin as a diagnostic and prognostic marker for sepsis caused by intestinal infection: a case report[J]. Eur Rev Med Pharmacol Sci, 2013, 17(10): 1311-1313.
[12] Dubos F, Korczowaski B, Aygun DA, et al. Serum procalcitonin level and other biological markers to distinguish between bacterial and a septic meningitis in children: a European multicenter case cohort study[J]. Anch Pediatric Adolesc Med, 2008, 162 (12):1157-1163.
[13] Ruiz-Alvarez MJ, Garcia-Valdecaseas S, De Pablo R, et al. Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis[J]. J Intensive Care Med, 2009, 24(1): 63-71.
[14] Suarez-Santamaria M, Santolaria F, Perez-Ramirez A. Prognostic value of inflammatory markers (notably cytokines and procalcitonin), nutritional assessment, and organ function in patients with sepsis[J]. Eur Cytokine Netw, 2010, 21(1): 19-26.
[15] Giamarellos-Bourboulis EJ. Tsangaris I, Karenni T, et al. Procalcitonin as an early indicator of outcome in sepsis:a prospective observation study[J]. J Hosp Infect, 2011, 77(1): 58-63.
[16] Arkader R, Troster EJ, Lopes MR, et al. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome[J]. Arch Dis Child, 2006, 91(2): 117-120.
[17] 邢豫宾, 戴路明, 赵焕之, 等.血清降钙素原和常用炎症指标结合SOFA评分对脓毒症早期诊断和预后价值的评价[J].中国危重病急救医学, 2008, 20(1): 23-28.
[18] 刘禹赓, 李春盛.全身炎症反应综合征患者凝血系统功能紊乱的研究[J].中华内科杂志, 2004, 43(2): 94-97.
[19] Vove C, Wnillemin WA. Zaerleder S. International Society on Thrombosis and Haemostasis score for over disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients[J]. Blood Coagul Fibrin Olysis, 2006, 17(6): 445-451.
[20] Dhainaut JF, Shorr AF, Macias WL, et al. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure[J]. Crit Care Med, 2005, 33(2): 341-348.
[21] 马晓春. 应重视脓毒症的抗凝治疗[J].中国危重病急救医学, 2010, 22(9): 516-517.
[22] 奚晶晶, 王红, 杨钧. 降钙素原在脓毒症患者中的动态变化及中药于预的影响[J].中国中医结合急救杂志, 2007, 14(6): 327-329.
[23] 占志刚, 李春盛．D-二聚体对急诊脓毒血症患者预后价值的前瞻性的研究[J]. 中国危重急救医学, 2012, 3(24): 135-139.